Suspected cancer: recognition and referral

Supporting evidence

• Surveillance report

• January 2025 exceptional surveillance of suspected cancer: recognition and referral (NICE guideline NG12)

• November 2024 exceptional surveillance of suspected cancer: recognition and referral (NICE guideline NG12)

• 2024 exceptional surveillance of suspected cancer: recognition and referral (NICE guideline NG12)

• May 2024 exceptional surveillance of suspected cancer: recognition and referral (NICE guideline NG12)

• March 2024 exceptional surveillance of suspected cancer: recognition and referral (NICE guideline NG12) and suspected neurological conditions: recognition and referral (NICE guideline NG127)

• 2022 exceptional surveillance of suspected cancer: recognition and referral (NICE guideline NG12) and quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care (NICE diagnostics guidance 30)

• Appendix A: Summary of evidence from surveillance (PDF 432 KB)

  Published:

  30 June 2022

• Appendix B: Stakeholder consultation comments table (PDF 850 KB)

  Published:

  30 June 2022

• September 2021 exceptional surveillance of suspected cancer: recognition and referral (NICE guideline NG12) and suspected neurological conditions: recognition and referral (NICE guideline NG127)

• March 2021 exceptional surveillance of suspected cancer: recognition and referral (NICE guideline NG12)

• 2020 Surveillance of suspected cancer: recognition and referral (NICE guideline NG12)

• Appendix A: Summary of evidence from surveillance (PDF 884 KB)

  Published:

  31 January 2020

• Appendix B: Stakeholder consultation comments table (PDF 1.21 MB)

  Published:

  31 January 2020

• Evidence review

• Evidence review - December 2021

• A: Diagnostic accuracy of prostate specific antigen (PSA) thresholds for referring people with suspected prostate cancer (PDF 2.28 MB)

  Published:

  15 December 2021

• Full guidance

• Appendices A–E (PDF 788 KB)

  Published:

  11 September 2020

• Appendix F (PDF 16.88 MB)

  Published:

  11 September 2020

• Appendix G (PDF 2.52 MB)

  Published:

  11 September 2020

• Appendix H (PDF 1.61 MB)

  Published:

  11 September 2020

• Appendix I (PDF 353 KB)

  Published:

  11 September 2020

• Appendix J1 (PDF 6.1 MB)

  Published:

  11 September 2020

• Appendix J2 (PDF 3.52 MB)

  Published:

  11 September 2020

• Appendix J3 (PDF 514 KB)

  Published:

  11 September 2020

• Appendix J4 (PDF 580 KB)

  Published:

  11 September 2020

• Full guideline (PDF 4.1 MB)

  Published:

  11 September 2020